Previous 10 | Next 10 |
Alkermes Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on ALKS 3831 PR Newswire DUBLIN, Oct. 7, 2020 DUBLIN , Oct. 7, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administrat...
Alkermes plc is a global biopharmaceutical company focused on developing and commercializing products related to schizophrenia, bipolar disorder, multiple sclerosis, and recently oncology. Alkermes has three therapeutics on the market, 1 in Regulatory review (passed Phase 3) and ...
The following slide deck was published by Alkermes plc in conjunction with this event. For further details see: Alkermes Plc (ALKS) Investor Presentation - Slideshow
Alkermes (NASDAQ: ALKS ) +1% presented new clinical data from ARTISTRY-1, an ongoing phase 1/2 study evaluating Alkermes' investigational engineered interleukin-2 variant immunotherapy, ALKS 4230, administered intravenously as monotherapy and in combination with the PD-1 inhi...
DUBLIN , Sept. 18, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today presented new clinical data from ARTISTRY-1, an ongoing phase 1/2 study evaluating Alkermes' investigational engineered interleukin-2 (IL-2) variant immunotherapy, ALKS 4230, administered intravenously as mon...
-- New Outcomes Research Analyzed Patterns of Weight Gain and Treatment Interruptions Associated With the Use of Second-Generation Oral Antipsychotics in Patients With Schizophrenia or Bipolar I Disorder -- -- Five Additional Poster Presentations Highlight Data Related to ALKS...
Volatility watch: Cinemark (NYSE: CNK ) and On Semiconductor (NASDAQ: ON ) have both seen sizable jumps in short interest positions, while the daily swings in Stitch Fix (NASDAQ: SFIX ) could to get large amid a high level of short interest even as Wall Street firms turn bullish. Op...
Subsidiaries of Alkermes plc (NASDAQ: ALKS ) have filed patent infringement litigation in a New Jersey court against Teva Pharmaceutical Industries (NYSE: TEVA ) regarding Teva's U.S. application seeking FDA approval of a generic version of alcohol/opioid dependence med Vivitrol (nal...
DUBLIN , Sept. 9, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that that its Chief Executive Officer, Richard Pops , will participate in a fireside chat at the Cantor Virtual Global Healthcare Conference on Wednesday, Sept. 16, 2020 at 10:40 a...
Company to Host Investor Webcast at 8:30 a.m. ET on Friday, Sept. 18, 2020 DUBLIN , Sept. 8, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it will present new clinical data related to ALKS 4230, its investigational engineered interleukin-2 (IL-2) ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-22 10:45:03 ET Enbridge Inc (ENB) ENB is trading UP for the last 5 days, and it at trading at $36.59 with volume of 731,965 and a one day change of $0.05 (0.14%). Enbridge Inc has a 52-week low of 31.03 and a 52-week high of $38.36. The business's 50-day moving average price...
Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...
2024-06-29 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...